Astrogen

Astrogen is deeply committed to its ESG policy, which aligns with our mission to create a better world through "human-centered science" and contribute to the "improvement of the quality of life for patients and their families," all while pursuing "sustainable happiness for all stakeholders." Guided by this policy, we prioritize environmental sustainability, social responsibility, and transparent governance in our operations.

As part of our ESG initiatives, we relentlessly strive to quickly research, develop, and commercialize new drugs that address the desperate needs of patients, drawing from our clinical experience. By going beyond mere treatment, we actively seek to contribute to the happiness of patients as their trusted partners. These efforts are integral to our commitment to sustainable growth and the creation of long-term value for all stakeholders.

Additionally, we recognize our responsibility as a member of the community, actively participating in initiatives that foster a "happy world together." Through collaboration and engagement, we seek to contribute positively to the collective well-being and happiness of society. Our ESG policy serves as the guiding force behind these endeavors, driving us to make a meaningful impact on both a local and global scale.